UCX MedFlight will ‘disrupt’ fixed-wing air ambulance industry
The industry as a whole is prime for a new entrant to disrupt the status quo and lead out with fresh ideas, new technology, and precision, said the organisation.
US-based UCX MedFlight, which announced the launch of global air ambulance services in February, has stated that it is set to ‘disrupt’ the fixed-wing air ambulance industry. The industry as a whole is prime for a new entrant to disrupt the status quo and lead out with fresh ideas, new technology, and precision, said the organisation. UCX MedFlight believes it is ‘uniquely positioned’ to pioneer these updates in global air ambulance services.
In a statement, the firm said: “The fixed-wing air ambulance/air medical transport industry has long been entrenched in old routines of inefficiency and dated technology. The frustrations of patients, families, caregivers, hospital case managers, insurance companies, and travel assistance companies are rooted in the fixed-wing air ambulance industry’s long history of unreliability, lack of customer service, non-transparent billing practices, and lack of consistency in training/capabilities.”
UCX MedFlight, which describes itself as ‘one of the most trusted names in medical air transportation’, added that it can fly faster, farther and less expensively than the historical standard set by operators in the fixed-wing air ambulance industry. The company is planning for rapid expansion, and has said it expects to gain 300 new staff members by February 2019.